FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804951311> ?p ?o ?g. }

• W2804951311 abstract "Health state (HS) utility values for patients with acute myeloid leukemia (AML), a hematological malignancy, are not available in the United Kingdom (UK). This study aims to develop clinically sound HSs for previously untreated patients with AML and to assign utility values based on preferences of the general UK population.This study was conducted in the UK and comprised 2 stages. During the first stage, AML HSs were drafted based on evidence from a literature review of AML clinical and health-related quality-of-life studies (published January 2000-June 2016) and patient-reported outcome measures previously used in this population. A panel of UK hematologists with AML experience validated the clinical relevance and accuracy of the HSs. During the second stage, validated HSs were valued in an elicitation survey with a representative UK population sample using the time trade-off (TTO) method. Descriptive statistics and bivariate tests were obtained and performed.A total of eight HSs were developed and clinically validated, including treatment with chemotherapy, consolidation therapy, transplant, graft-vs-host disease (GvHD), remission, relapse, refractory, and functionally cured. In total, 125 adults participated (mean age, 49.6 years [range, 18-87 years], 52.8% female). Mean (95% confidence interval [CI]) TTO preference values (n = 120), ranked from lowest (worst HS) to highest (best HS) were as follows: refractory - 0.11 (- 0.21 to - 0.01), relapse 0.10 (0.00-0.20), transplant 0.28 (0.20-0.37), treatment with chemotherapy 0.36 (0.28-0.43), GvHD 0.43 (0.36-0.50), consolidation 0.46 (0.40-0.53), remission 0.62 (0.57-0.67), and functionally cured 0.76 (0.72-0.79). Mean (95% CI) visual analog scale preference values followed the same rank order, ranging from 0.15 (0.13-0.17) for refractory to 0.71 (0.68-0.73) for functionally cured.To our knowledge, this is the first study to report utility values for AML from the UK societal perspective. Participants were able to distinguish differences in severity among AML HSs, and preference values were consistent with clinical perception of HS severity. HS preference values observed in this study may be useful in future evaluations of treatment benefit, including cost-effectiveness analyses and improved patient well-being." @default.
• W2804951311 created "2018-06-01" @default.
• W2804951311 creator A5000314598 @default.
• W2804951311 creator A5023276607 @default.
• W2804951311 creator A5054782578 @default.
• W2804951311 creator A5084480834 @default.
• W2804951311 creator A5090399884 @default.
• W2804951311 creator A5091010043 @default.
• W2804951311 creator A5091669022 @default.
• W2804951311 date "2018-04-18" @default.
• W2804951311 modified "2023-10-13" @default.
• W2804951311 title "Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom" @default.
• W2804951311 cites W1977380325 @default.
• W2804951311 cites W1982206457 @default.
• W2804951311 cites W1996198481 @default.
• W2804951311 cites W1998475390 @default.
• W2804951311 cites W2010026460 @default.
• W2804951311 cites W2024755659 @default.
• W2804951311 cites W2051593700 @default.
• W2804951311 cites W2065464763 @default.
• W2804951311 cites W2081576971 @default.
• W2804951311 cites W2082269822 @default.
• W2804951311 cites W2083611552 @default.
• W2804951311 cites W2098122189 @default.
• W2804951311 cites W2101278441 @default.
• W2804951311 cites W2101491001 @default.
• W2804951311 cites W2109065151 @default.
• W2804951311 cites W2148370712 @default.
• W2804951311 cites W2153836018 @default.
• W2804951311 cites W2160746673 @default.
• W2804951311 cites W2167571044 @default.
• W2804951311 cites W2179875419 @default.
• W2804951311 cites W2237124828 @default.
• W2804951311 cites W2473786944 @default.
• W2804951311 cites W2516611622 @default.
• W2804951311 cites W2518995482 @default.
• W2804951311 cites W2543324947 @default.
• W2804951311 cites W2559537906 @default.
• W2804951311 doi "https://doi.org/10.1186/s12955-018-0897-8" @default.
• W2804951311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5907377" @default.
• W2804951311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29669568" @default.
• W2804951311 hasPublicationYear "2018" @default.
• W2804951311 type Work @default.
• W2804951311 sameAs 2804951311 @default.
• W2804951311 citedByCount "9" @default.
• W2804951311 countsByYear W28049513112019 @default.
• W2804951311 countsByYear W28049513112020 @default.
• W2804951311 countsByYear W28049513112021 @default.
• W2804951311 countsByYear W28049513112022 @default.
• W2804951311 countsByYear W28049513112023 @default.
• W2804951311 crossrefType "journal-article" @default.
• W2804951311 hasAuthorship W2804951311A5000314598 @default.
• W2804951311 hasAuthorship W2804951311A5023276607 @default.
• W2804951311 hasAuthorship W2804951311A5054782578 @default.
• W2804951311 hasAuthorship W2804951311A5084480834 @default.
• W2804951311 hasAuthorship W2804951311A5090399884 @default.
• W2804951311 hasAuthorship W2804951311A5091010043 @default.
• W2804951311 hasAuthorship W2804951311A5091669022 @default.
• W2804951311 hasBestOaLocation W28049513111 @default.
• W2804951311 hasConcept C126322002 @default.
• W2804951311 hasConcept C159110408 @default.
• W2804951311 hasConcept C187212893 @default.
• W2804951311 hasConcept C2777491762 @default.
• W2804951311 hasConcept C2778729363 @default.
• W2804951311 hasConcept C2779951463 @default.
• W2804951311 hasConcept C2908647359 @default.
• W2804951311 hasConcept C44249647 @default.
• W2804951311 hasConcept C71924100 @default.
• W2804951311 hasConcept C99454951 @default.
• W2804951311 hasConceptScore W2804951311C126322002 @default.
• W2804951311 hasConceptScore W2804951311C159110408 @default.
• W2804951311 hasConceptScore W2804951311C187212893 @default.
• W2804951311 hasConceptScore W2804951311C2777491762 @default.
• W2804951311 hasConceptScore W2804951311C2778729363 @default.
• W2804951311 hasConceptScore W2804951311C2779951463 @default.
• W2804951311 hasConceptScore W2804951311C2908647359 @default.
• W2804951311 hasConceptScore W2804951311C44249647 @default.
• W2804951311 hasConceptScore W2804951311C71924100 @default.
• W2804951311 hasConceptScore W2804951311C99454951 @default.
• W2804951311 hasFunder F4320307765 @default.
• W2804951311 hasIssue "1" @default.
• W2804951311 hasLocation W28049513111 @default.
• W2804951311 hasLocation W28049513112 @default.
• W2804951311 hasLocation W28049513113 @default.
• W2804951311 hasLocation W28049513114 @default.
• W2804951311 hasLocation W28049513115 @default.
• W2804951311 hasOpenAccess W2804951311 @default.
• W2804951311 hasPrimaryLocation W28049513111 @default.
• W2804951311 hasRelatedWork W2002075945 @default.
• W2804951311 hasRelatedWork W2352080890 @default.
• W2804951311 hasRelatedWork W2410491650 @default.
• W2804951311 hasRelatedWork W2604682584 @default.
• W2804951311 hasRelatedWork W2752094163 @default.
• W2804951311 hasRelatedWork W2972456598 @default.
• W2804951311 hasRelatedWork W3036527747 @default.
• W2804951311 hasRelatedWork W4242858705 @default.
• W2804951311 hasRelatedWork W4249139583 @default.
• W2804951311 hasRelatedWork W4307034070 @default.
• W2804951311 hasVolume "16" @default.
• W2804951311 isParatext "false" @default.

• next